IMMUNIC, INC. — Director's Dealing 2022

Dec 15, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2022-12-13

Reporting Person: Neermann Joerg (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-13	Common Stock	P	35000	$1.246	Acquired	53000	Direct
2022-12-14	Common Stock	P	47000	$1.256	Acquired	100000	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.23 to $1.28 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought by him at each separate price on December 13, 2022.

F2: The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $1.22 to $1.28 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought by him at each separate price on December 14, 2022.